Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Nov.26.2025

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.

2Firsts, November 26, 2025 — According to GuruFocus, Organigram Global has appointed James Yamanaka, who previously served as Global Head of Strategy at British American Tobacco (BTI), as its new Chief Executive Officer.

James Yamanaka: One purpose, many changes - Sustainable Japan by The Japan Times — James Yamanaka｜sustainable

His appointment is expected to take effect around January 15, 2026, at which point he will also join the company’s board of directors.

The report notes that Yamanaka spent more than two decades at BTI, holding strategic planning and general management roles across Europe and Asia. His career includes work on value-driven strategy development, operational transformation and commercial performance improvement.

References:

[1] BTI Executive James Yamanaka to Lead Organigram Global as New CEO

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Arizona Rules Extend Across Alternative Nicotine Supply Chain, With Licensing From 2028

Arizona Rules Extend Across Alternative Nicotine Supply Chain, With Licensing From 2028

Arizona Governor Katie Hobbs has signed HB 4001, bringing alternative nicotine products under a new state regulatory framework that will require maker and distributor licensing from 2028 and ban packaging designs that could appeal to minors.

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches

The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations

Jun.26 by 2Firsts Perspectives

Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate

Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate

Former ATF Deputy Director Edgar Domenech has warned that some Chinese vape companies may be using 6-methyl nicotine, a nicotine analogue, raising new questions over how US regulators should classify emerging nicotine compounds.

EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections

EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections

An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.

Related Topics

Related Read

Arizona Rules Extend Across Alternative Nicotine Supply Chain, With Licensing From 2028

Arizona Rules Extend Across Alternative Nicotine Supply Chain, With Licensing From 2028

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

2Firsts Perspectives

Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate

Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate

EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections

EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections